Active Surveillance on Safety and Compliance of Freeze-dried Human Rabies Vaccine (Vero Cell) — Jiangsu Province, China, 2023–2024
This study supports broader adoption of the 4-dose regimen to reduce logistical challenges and enhance compliance. Mobile application-based active surveillance presents a novel approach to enhancing real-world monitoring quality.
Authors
- Yanjun Chen (ORCID: https://orcid.org/0009-0002-0701-3747)
- Pan HongXing (ORCID: https://orcid.org/0000-0002-3791-1241)
- Mingwei Wei
- Shixuan Zhang (ORCID: https://orcid.org/0000-0002-5723-9747)
- Xue Guo
- Liang Qi (ORCID: https://orcid.org/0000-0002-0235-7957)
- Yunfeng Shi (ORCID: https://orcid.org/0000-0003-1700-6049)
- Chenhao Wang
- Xu Xiaoteng (ORCID: https://orcid.org/0000-0002-4420-4369)
Institutions
- Changchun Institute of Biological Products (CN)
- Jiangsu Provincial Center for Disease Control and Prevention (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- China CDC Weekly
- Published
- 2025-01-01
- DOI
- https://doi.org/10.46234/ccdcw2025.210
- Primary Topic
- Rabies epidemiology and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00